What is AbbVie's common stock, shares authorized (in shares)?

AbbVie (ABBV) reported common stock, shares authorized (in shares) of 4B in Q1 2026.

How has AbbVie's common stock, shares authorized (in shares) changed year-over-year?

AbbVie's common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from 4B to 4B.

What is the long-term trend for AbbVie's common stock, shares authorized (in shares)?

Over 5 years (2020 to 2025), AbbVie's common stock, shares authorized (in shares) has grown at a 0.0% compound annual growth rate (CAGR), from 4B to 4B.

AbbVie ABBV Common stock, shares authorized (in shares)

Common stock, shares authorized (in shares) at other companies

AmgenAMGN

——

Cardinal HealthCAH

——

Vertex PharmaceuticalsVRTX

——

IncyteINCY

——

McKessonMCK

——

Avalo TherapeuticsAVTX

——

Other financials

Income statement

See full

Revenue$15.0B+12.4%

Gross profit$10.8B+15.4%

Operating income$4.0B+6.9%

Net income$695.0M-46.0%

EPS (diluted)$0.39-45.8%

Balance sheet

See full

Cash & equivalents$9.4B+81.5%

Total debt$62.4B+1.8%

Total equity-$6.7B-569%

Total assets$136.46B+0.2%

Cash flow

See full

Operating cash flow$3.8B+134%

CapEx$265.0M+12.8%

Free cash flow$3.6B+155%

Valuation

See full

Market cap$444.6B+39.8%

P/E122.3×+37.8×

P/S7.1×+1.6×

Profitability

See full

Gross margin70.7%0.0pp

Operating margin24.4%—

Net margin5.8%-1.5pp

FCF margin31.8%+5.0pp

Returns & leverage

See full

Return on equity89%+32.7pp

Debt / equity46.6×+38.6×

Current ratio0.8×0.0×

Where this comes from

Reported directly by AbbVie in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The official record: AbbVie’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about AbbVie's common stock, shares authorized (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is AbbVie's common stock, shares authorized (in shares)?: AbbVie (ABBV) reported common stock, shares authorized (in shares) of 4B in Q1 2026.
How has AbbVie's common stock, shares authorized (in shares) changed year-over-year?: AbbVie's common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from 4B to 4B.
What is the long-term trend for AbbVie's common stock, shares authorized (in shares)?: Over 5 years (2020 to 2025), AbbVie's common stock, shares authorized (in shares) has grown at a 0.0% compound annual growth rate (CAGR), from 4B to 4B.